R
RiverVest
Venture CapitalActiveRiverVest is a venture capital firm which focuses on identifying and shaping early stage life science companies to create shareholder value.
59
Investments
15
Exits
$275M
AUM
25.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for RiverVest.
Investment Thesis & Strategy
RiverVest invests in early-stage life science companies, aiming to build shareholder value. They focus on identifying and shaping these companies.
Investment Activity
Deals per year over the last 8 years
3
20161
20170
20181
20191
20204
20211
20221
2023Portfolio Companies
Selected investments from their portfolio of 59 companies
A
Ablaze Pharmaceuticals
Biotech · Series A, 2023
O
Obsidio
Healthcare · Series A, 2022
S
Senda Biosciences
Biotech · Series A, 2021
V
VentureMed Group
Healthcare · Series A, 2021
X
Xalud Therapeutics
Biotech · Series A, 2021
V
Vaxxinity
Biotech · Series B, 2021
C
CardioNexus
Healthcare · Series A, 2020
I
Inscripta
Biotech · Series C+, 2019
A
Avenue Therapeutics
Biotech · Series A, 2017
C
Confluent Medical Technologies
Healthcare · Growth, 2016
R
Rani Therapeutics
Biotech · Series C+, 2016
Z
Zentalis Pharmaceuticals
Biotech · Series B, 2016
Frequently Asked Questions
RiverVest focuses on Series A, Series B, Series C+ stage investments.